Hepatopulmonary Syndrome clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Letrozole in Patients With Hepatopulmonary Syndrome
open to eligible people ages 18-99
The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.
at UCSF
Last updated: